- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Benign Prostatic Hyperplasia in Colombia
Total 472 results
-
CMX ResearchFerring PharmaceuticalsCompleted
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Recruiting
-
AstraZenecaCompletedNon-metastatic Prostate CancerUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompleted
-
CMX ResearchSanofiCompleted
-
Canadian Cancer Trials GroupEndocyte; Prostate Cancer CanadaActive, not recruiting
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
DendreonCompleted
-
Coherus Biosciences, Inc.Arcus Biosciences, Inc.; Surface OncologyTerminatedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
US Department of Veterans AffairsCompleted
-
SonaCare MedicalUnknownRecurrent Prostate CancerUnited States, Canada
-
Veru Inc.TerminatedMetastatic Castration-resistant Prostate Cancer | Androgen Resistant Prostatic CancerUnited States
-
Northwest BiotherapeuticsWithdrawnProstate CancerUnited States
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
Canadian Cancer Trials GroupOncolytics BiotechCompleted
-
Canadian Cancer Trials GroupCanadian Cancer Society (CCS)RecruitingProstate Cancer MetastaticCanada
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruitingProstate CancerCanada
-
Achieve Life SciencesTeva Pharmaceuticals USATerminatedHormone Refractory Prostate Cancer | Castrate-Resistant Prostate CancerFrance, United States, Spain, United Kingdom, Canada
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
University of British ColumbiaUniversity Health Network, Toronto; Janssen Inc.RecruitingGenomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer (GUNS)Prostate CancerCanada, United States
-
Medstar Health Research InstituteGeorgetown University; George Washington University; Howard UniversityRecruitingBreast Cancer | Prostate Cancer | Social Determinants of Health | Disparities | Health EquityUnited States
-
DendreonTerminatedProstate CancerUnited States
-
RPCR, Inc.UnknownProstate Cancer Early Risk Treated by Radiosurgery | Prostate Cancer Intermediate Risk Treated by RadiosurgeryUnited States
-
Canadian Cancer Trials GroupCanadian Cancer Clinical Trials Network; BC Cancer FoundationActive, not recruiting
-
Georgetown UniversityCompletedPhysical Activity | Metabolic Syndrome | Prostate CancerUnited States
-
Ferring PharmaceuticalsCompleted
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostatic Adenocarcinoma | Castration Levels of TestosteroneUnited States, Switzerland, Mexico, Chile, Colombia
-
NCIC Clinical Trials GroupS*BIOCompleted
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI)Completed
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticCanada, United States, France, United Kingdom
-
ExelixisTerminatedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States, Canada, Australia, United Kingdom, Ireland
-
Centre hospitalier de l'Université de Montréal...McMaster University; Queen's University; London Health Sciences Centre; Canadian... and other collaboratorsActive, not recruiting
-
Astellas Pharma Global Development, Inc.PfizerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerUnited States
-
GlaxoSmithKlineCompletedNeoplasms, ProstateUnited States, Canada
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Czech Republic, Hungary, Romania, Canada
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Belgium, Netherlands, Canada, Russian Federation, Finland, Former Serbia and Montenegro, France, Germany, Romania, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
LTN PHARMACEUTICALS, INC.TerminatedProstate CancerUnited States, Canada
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
CMX ResearchSanofiCompleted
-
AbbVieJSS Medical Research; CMX Research Inc.; Canadian Urology Research ConsortiumCompleted
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
British Columbia Cancer AgencyRecruitingProstatic Cancer | Prostatic NeoplasmCanada